[ad_1] The Food and Drug Administration has approved the injection of Eli Lilly (NYSE: LLY) for the preventive treatment of migraine in adults, one of three drugs in a new class recently …
Read More »Eli Lilly Says FDA Approves New Migraine Medicine – Amgen Inc. (NASDAQ: AMGN)
